The Implantable Defibrillators Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Implantable Defibrillators Market:
https://www.thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report
In accordance with The Business Research Company’s comprehensive analysis in the Implantable Defibrillators Global Market Report for 2024, the market for implantable defibrillators has demonstrated a consistent upward trajectory. Projections indicate a rise from $5.46 billion in 2024 to an estimated $5.69 billion by the end of the same year, showcasing a commendable compound annual growth rate (CAGR) of 4.2%. This growth during the historical period can be primarily attributed to an escalating prevalence of cardiac disorders, robust clinical evidence and research, a burgeoning aging population, heightened awareness and educational initiatives, along with strategic collaborations and partnerships.
Anticipated to sustain its momentum, the implantable defibrillators market is poised for substantial expansion, reaching $6.82 billion by 2028, with a projected CAGR of 4.6%. Factors influencing this growth in the forecast period include the seamless integration of remote monitoring and telemedicine, an expanded spectrum of indications, an intensified focus on heart failure management, the implementation of personalized medicine approaches, and the global augmentation of healthcare infrastructure. Noteworthy trends in this period encompass the evolution towards miniaturization and design innovations, the pervasive influence of remote monitoring and connectivity, the advent of personalized therapy approaches, the emergence of leadless implantable defibrillators, and advancements in battery technology.
The increase in the prevalence of sudden cardiac arrest is expected to boost the growth of the implantable defibrillators market. Sudden cardiac arrest (SCA) refers to a condition where the heart stops beating unexpectedly. Implantable defibrillators can provide lifesaving therapy by detecting and correcting abnormal heart rhythms that can lead to SCA. For instance, according to a report published by the Journal of the American College of Cardiology, a US-based medical journal, SCD causes 185,000 to 450,000 deaths annually in the US population or 7% to 18% of all fatalities. Therefore, the increase in the prevalence of sudden cardiac arrest is driving the growth of the implantable defibrillators market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10140&type=smp
The implantable defibrillators market covered in this report is segmented –
1) By Product Type: Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators
2) By Procedure Type: Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Top 5 Major Players:
- Boston Scientific Corporation
- LivaNova PLC
- Biotronik SE & Co KG
- MicroPort Scientific Corporation
- Mayo Clinic
A pivotal trend gaining significant traction in the implantable defibrillators market is product innovation. Key industry players are strategically channeling their efforts into the development of groundbreaking products to maintain a competitive edge. A case in point is Medtronic, an Ireland-based medical device company, which, in December 2024, unveiled its revolutionary implantable cardioverter-defibrillator known as the Aurora extravascular ICD. Distinguished by its placement under the skin beneath the left armpit, as opposed to the conventional collarbone insertion, this device mirrors the size, shape, and battery life of traditional transvenous ICDs. The Aurora ICD offers defibrillation during cardiac arrest and ongoing pacemaker therapies, with its Epsila leads minimally invasively connected to the heart beneath the breastbone. Additionally, the implant incorporates Medtronic’s cutting-edge Smart Sense technology, mitigating the risk of unwarranted shocks, and SureScan technology, enabling patients to undergo MRI procedures with the device in place. This noteworthy development underscores the industry’s commitment to advancing patient care through innovative solutions.
1. Executive Summary
2. Implantable Defibrillators Market Characteristics
3. Implantable Defibrillators Market Trends And Strategies
4. Implantable Defibrillators Market – Macro Economic Scenario
5. Global Implantable Defibrillators Market Size and Growth
….
31. Global Implantable Defibrillators Market Competitive Benchmarking
32. Global Implantable Defibrillators Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Implantable Defibrillators Market
34. Implantable Defibrillators Market Future Outlook and Potential Analysis
35. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Implantable Defibrillators Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Implantable Defibrillators Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Implantable Defibrillators Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…
Table 74: Boston Scientific Corporation Financial Performance
Table 75: LivaNova PLC Financial Performance
Table 76: Biotronik SE & Co KG Financial Performance
Table 77: MicroPort Scientific Corporation Financial Performance
Table 78: Mayo Clinic Financial Performance
Related Reports:
https://topprnews.com/diet-pills-market-analysis/
https://topprnews.com/diffuse-large-b-cell-lymphoma-therapeutics-market-size/
https://topprnews.com/digital-ad-spending-market-size/
https://goodprnews.com/diet-pills-market-analysis/
https://goodprnews.com/diffuse-large-b-cell-lymphoma-therapeutics-market-size/
https://goodprnews.com/digital-ad-spending-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
